Skip to main content

JAG CAPITAL MANAGEMENT, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1080374 ST LOUIS, MO

Position in GILD

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$3,300,379
-$13,622,901 QoQ
Shares Held
26,123
-78.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#689
of 2,266 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

JAG CAPITAL MANAGEMENT, LLC holds $31,314,287 across 6 Drug Manufacturers - General names. GILD ranks #2 (10.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 GILD
Gilead Sciences, Inc.
This page
26,123 $3,300,379

All Filings in GILD

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,300,379 26,123
2026-03-31 $16,923,280 121,427
2025-12-31 $13,759,276 112,101
2023-12-31 $1,315,197 16,235
2023-09-30 $1,209,906 16,145
2023-06-30 $1,196,665 15,527
2023-03-31 $1,267,283 15,274
2022-12-31 $1,425,625 16,606
2022-09-30 $887,225 14,382
2022-06-30 $890,867 14,413
2022-03-31 $1,118,432 18,813
2021-12-31 $1,158,710 15,958
2021-09-30 $1,116,691 15,987
2021-06-30 $1,334,437 19,379
2021-03-31 $1,249,491 19,333
2020-12-31 $1,156,810 19,856
2020-09-30 $1,319,280 20,878
2020-06-30 $1,560,804 20,286
2020-03-31 $13,064,609 174,754